Reducing new HIV infections among injecting drug users
Title VII — Addressing high-impact minority diseases › Subtitle E — HIV/AIDS
Read this section in the full bill →
This section appears in one version only, so there is nothing to compare yet.
(a) Sense of congress It is the sense of Congress that providing sterile syringes and sterilized equipment to injecting drug users substantially reduces risk of HIV infection, increases the probability that they will initiate drug treatment, and does not increase drug use. (b) In general The Secretary of Health and Human Services may provide grants and technical assistance for the purpose of reducing the rate of HIV infections among injecting drug users through a comprehensive package of services for such users, including the provision of sterile syringes, education and outreach, access to infectious disease testing, overdose prevention, and treatment for drug dependence. (c) Authorization of appropriations To carry out this section, there are authorized to be appropriated such sums as may be necessary for fiscal years 2027 through 2030.